Francesco Lippi
Proffesor
University of Pisa
Italy
Biography
Francesco Lippi is Graduated in Medicine and Surgery at the University of Pisa, Albo Pisa 1879/79. Specialization in Endocrinology at the University of Pisa July 1982. Specialization in Nuclear Medicine at the University of Florence July 1987. He has taught at the Institute of Clinical Methodology and the Institute of Endocrinology of the University of Pisa. From 1990 as a Professor of Endocrinology at the University Hospital of Pisa. He conducted the study (page se III) on the effects of recombinant human TSH (rhTSH) adjuvant therapy in a compassionate use program for patients with differentiated thyroid carcinoma. Then used a low activity of radioiodine therapy for the treatment of thyroid remnants after surgery using rhTSH therapy without withdrawal l-thyroxine. After the Chernobyl accident participate in the European Commission Study for diagnosis and treatment of children exposed to radiations or radioactive follow-out (1990-1995). He held master's and refresher courses in Endocrinology and Nuclear Medicine at Stanford University (USA) for the treatment of thyroid carcinoma with rhTSH. He held an updated master's degree at the Mayo Clinic in Rochester (USA). Associate of scientific associations in the field of Endocrinology as Endocrine Society, American Thyroid Association, European Thyroid Association, and Medical Endocrinologist Association (AME).
Research Interest
Endocrinology, Nuclear Medicine, thyroid carcinoma